federal_register: 2025-08607
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08607 | Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request | Notice | The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' draft guidance for the third cycle of the Medicare Drug Price Negotiation Program, the first cycle of renegotiation, and manufacturer effectuation of the maximum fair price for 2026, 2027, and 2028 for the implementation of the Inflation Reduction Act (IRA). | 2025-05-15 | 2025 | 5 | https://www.federalregister.gov/documents/2025/05/15/2025-08607/medicare-program-inflation-reduction-act-ira-medicare-drug-price-negotiation-program-draft-guidance | https://www.govinfo.gov/content/pkg/FR-2025-05-15/pdf/2025-08607.pdf | Health and Human Services Department; Centers for Medicare & Medicaid Services | 221,45 | The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' draft guidance for the third cycle of the Medicare Drug Price Negotiation Program, the first cycle of renegotiation, and manufacturer... |